Skip to main content

Table 1 Mean body weight (±SD) and mean ADWG (±SD) per treatment group

From: Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions

PCV-2 experiment treatment groups

Body Weight (Kg)

ADWG (Kg)

SD-5

SD62

SD83

ADWG SD5-SD62

ADWG SD62-SD83

ADWG SD5-SD83

NV-NC

3.80 ± 0.85

41.95 ± 8.75

63.43 ± 9.25

0.57 ± 0.12

1.02 ± 0.10

0.68 ± 0.10

NV-C PCV-2

3.81 ± 0.68

38.80 ± 6.31

60.61 ± 7.56

0.52 ± 0.09

1.04 ± 0.13

0.65 ± 0.08

VS-C PCV-2

3.69 ± 0,49

37.25 ± 6.16

56.96 ± 8,15

0.50 ± 0.09

0.94 ± 0.19

0.61 ± 0.09

VC-C PCV-2

3.65 ± 0.52

37.31 ± 4.27

57.61 ± 5.52

0.50 ± 0.06

0.97 ± 0.11

0.61 ± 0.06

Mhyo experiment treatment groups

Body Weight (Kg)

ADWG (Kg)

SD-5

SD62

SD91

ADWG SD5-SD62

ADWG SD62-SD91

ADWG SD5-SD91

NV-NC

3.80 ± 0.85

41.95 ± 8.75

70,22 ± 4.66

0.57 ± 0.12

1.05 ± 0.11

0.69 ± 0.05

NV-C Mhyo

3.77 ± 0.65

39.51 ± 4.96

66.09 ± 10.67

0.53 ± 0.07

0.92 ± 0.25

0.65 ± 0.11

VS-C Mhyo

3.77 ± 0.63

36.97 ± 4.30

64.48 ± 5.93

0.50 ± 0.06

0.95 ± 0.11

0.63 ± 0.06

VC-C Mhyo

3.81 ± 0.69

41.06 ± 4.86

70.33 ± 5.85

0.55 ± 0.06

1.01 ± 0.07

0.69 ± 0.06